4.11
Schlusskurs vom Vortag:
$4.21
Offen:
$4.17
24-Stunden-Volumen:
194.79K
Relative Volume:
1.12
Marktkapitalisierung:
$172.10M
Einnahmen:
$52.84M
Nettoeinkommen (Verlust:
$-11.11M
KGV:
-14.99
EPS:
-0.2742
Netto-Cashflow:
$-9.12M
1W Leistung:
-11.61%
1M Leistung:
+6.20%
6M Leistung:
+10.78%
1J Leistung:
+140.35%
Apyx Medical Corp Stock (APYX) Company Profile
Firmenname
Apyx Medical Corp
Sektor
Branche
Telefon
(727) 384-2323
Adresse
5115 ULMERTON ROAD, CLEARWATER, FL
Compare APYX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
APYX
Apyx Medical Corp
|
4.11 | 172.10M | 52.84M | -11.11M | -9.12M | -0.2742 |
|
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Apyx Medical Corp Stock (APYX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-11 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-12-16 | Eingeleitet | Roth Capital | Buy |
| 2025-11-14 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-11-12 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2024-10-17 | Eingeleitet | BTIG Research | Neutral |
| 2023-07-14 | Eingeleitet | Stephens | Overweight |
| 2022-05-20 | Eingeleitet | Lake Street | Buy |
| 2019-04-02 | Bestätigt | Dougherty & Company | Buy |
Alle ansehen
Apyx Medical Corp Aktie (APYX) Neueste Nachrichten
Apyx Medical Corporation (APYX): a High Growth Micro-Cap Stock Improving Cellulite and Skin laxity - Insider Monkey
Apyx Medical Corp (APYX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Apyx Medical Corp (APYX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Apyx Medical Corp (APYX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Apyx Medical Corp (APYX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Apyx Medical Corp (APYX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Apyx Medical Corp (APYX) Institutional Confidence - TradingKey
Apyx Medical Corp (APYX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Apyx Medical (NASDAQ: APYX) COO nets 4,467 shares after option exercise - Stock Titan
Apyx Medical (NASDAQ: APYX) adds Executive Chairman, awards 450,000 RSUs - Stock Titan
Apyx Medical Corp (APYX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Apyx Medical (NASDAQ: APYX) director receives grant of 50,000 stock options - Stock Titan
Apyx Medical (APYX) CFO awarded 132,066 stock options at $4.65 - Stock Titan
Apyx Medical (APYX) Sr. VP granted 63,392 stock options at $4.65 strike - Stock Titan
Apyx Medical (NASDAQ: APYX) director awarded 450,000 restricted stock units - Stock Titan
Apyx Medical (NASDAQ: APYX) CEO awarded 213,948 stock options - Stock Titan
Apyx Medical (NASDAQ: APYX) COO awarded stock options on 88,044 shares - Stock Titan
[Form 4] Apyx Medical Corp Insider Trading Activity - Stock Titan
Apyx Medical (NASDAQ: APYX) director receives 50,000 stock options at $4.65 strike - Stock Titan
Apyx Medical Corp. Hits New 52-Week High of $4.65 - MarketsMojo
Apyx Medical Corp. Hits New 52-Week High of $4.97, Up 198% - MarketsMojo
How The Apyx Medical (APYX) Story Is Shifting With AYON, GLP 1 Demand And 2026 Goals - Yahoo Finance
Apyx Medical Shares Rise 6% as Body-Contouring Push Hits New Milestone - Bez Kabli
Real Renuvion patients hit the runway in Apyx’s Miami Swim Week show - Stock Titan
Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway - PR Newswire
APYX Q1 2026 Earnings: EPS Beats Expectations Despite Revenue UncertaintyEarnings Momentum Score - The Legal Advocate
APYX Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Surprise But Stock DeclinesROIC Trend Report - The Legal Advocate
APYX Technical Analysis | Trend, Signals & Chart Patterns | APYX MEDICAL CORP (NASDAQ:APYX) - ChartMill
New Apyx Medical (APYX) data backs Avéli and Renuvion cellulite treatment - Stock Titan
Why is DeFi Development Corp. (DFDV) Betting on Apyx - Kavout
Apyx Medical reports clinical data on cellulite treatment - Investing.com
One-session cellulite study shows visible dimple reduction, tighter skin - Stock Titan
APYX Stock Price, Quote & Chart | APYX MEDICAL CORP (NASDAQ:APYX) - ChartMill
Why Apyx Medical (APYX) Just Dropped -6.88% — What to Watch 2026-05-15Popular Market Picks - newser.com
TradingKey - TradingKey
Apyx Medical Announces Positive Clinical Outcomes for Renuvion and Launches AYON Body Contouring System in May 2026 - Minichart
Apyx Medical study shows improved satisfaction with Renuvion - Investing.com
Apyx Medical study: Renuvion with liposuction shows higher patient satisfaction, lower revision and abdominoplasty rates - TradingView
Apyx Medical (NASDAQ: APYX) study shows Renuvion boosts liposuction satisfaction - Stock Titan
New 113-patient study links Renuvion lipo to fewer repeat surgeries - Stock Titan
Apyx Medical receives FDA clearance for power liposuction feature By Investing.com - Investing.com South Africa
Apyx Medical Corporation Files Form 8-K Reporting Company Information and SEC Compliance Details - Minichart
Apyx Medical receives FDA clearance for power liposuction feature - Investing.com
Apyx Medical receives FDA 510(k) expansion for AYON to add power liposuction - TradingView
[8-K] Apyx Medical Corp Reports Material Event - Stock Titan
Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System - ChartMill
Apyx Medical Corporation (NASDAQ:APYX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$6.50 - Yahoo Finance
Apyx Medical Corporation (NASDAQ:APYX) Q1 2026 Earnings Call Transcript - Insider Monkey
Apyx Medical Corp 2026 Q1 Financial Results: Key Highlights, Net Loss, and Business Developments - Minichart
Apyx raises 2026 revenue outlook to $59M-$60M as AYON demand ramps - MSN
Apyx Medical (NASDAQ: APYX) grows Q1 2026 sales 32%, narrows loss - Stock Titan
Finanzdaten der Apyx Medical Corp-Aktie (APYX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Apyx Medical Corp-Aktie (APYX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| CITRONOWICZ MOSHE | Senior Vice President |
Mar 15 '26 |
Option Exercise |
1.80 |
37,000 |
66,600 |
493,504 |
| Roman Shawn David | Chief Operating Officer |
Jan 27 '26 |
Option Exercise |
1.80 |
12,000 |
21,600 |
12,000 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):